RAS Mutation

SAN DIEGO, July 13, 2026 Oncolytics Biotech announced a significant clinical and regulatory update for its REO 033 randomized...

SAN DIEGO, Calif., May 21, 2026 Cardiff Oncology, Inc. announced that updated data from its ongoing Phase 2 CRDF-004...

SAN DIEGO, May 04, 2026 Oncolytics Biotech® Inc. has reported compelling durability data from its REO 022 study, highlighting...